Terra Innovatumhas accelerated its go-to-market plans for cancer isotope production with the SOLO micro-modular reactor. Terra Innovatum is developing collaborative business models and frameworks to engage with leading isotope producers and distributors such as NorthStar, ANSTO, BWXT Medical, IRE, NRG, NTP Radioisotopes, and Nordion to broaden access, strengthen partnerships, and expand global market reach.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSRT:
- Terra Innovatum signs MOU with RAIT 88
- GSR III Acquisition, Terra Innovatum urge shareholders to approve combination
- GSR III Acquisition Corp Secures $31.8M PIPE Financing
- Terra Innovatum, Ameresco to pursue public-private commercial opportunities
- GSR III Acquisition, Terra Innovatum announce $37.5M equity financing